What's breaking now, across thousands of outlets.
‘The litigation did not originate with Mr. Ward, and its factual and legal foundation does not depend upon him,’ said the lawyer for dozens of Canadian soldiers and ex-soldiers named in the lawsuit
We haven't written up this one. National Post has the full story — the link below goes straight to it.
MILAN — Weight loss with Zealand and Roche’s amylin analog was regarded as disappointing when its Phase 2 obesity trial reported topline data in March.
Merck agreed to pay SciBrunch up to $2.13 billion consisting of $400 million upfront and the remainder in payments tied to achieving milestones across multiple indications.
MILAN — Lilly said Tuesday that its triple agonist, called retatrutide, helped patients with both obesity and type 2 diabetes to lose up to 18.8% of their weight after about a year and a half.
Penn Badgley infamously swore off sex scenes before the production of “You” Season 4, revealing on a viral episode of his “Podcrushed” podcast in Feb.
Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
Taylor Swift's 'Patient Zero' inverts the term's meaning — and her video goes further. The real history: a misread letter, a scapegoat, a posthumous vindication.
